Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Article
|
The evolving role of preprints in the dissemination of COVID-19 research and their impact on the science communication landscapePLoS biology, 2021-04, Vol.19 (4), p.e3000959-e3000959 [Peer Reviewed Journal]2021 Fraser et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 Fraser et al 2021 Fraser et al ;ISSN: 1545-7885 ;ISSN: 1544-9173 ;EISSN: 1545-7885 ;DOI: 10.1371/journal.pbio.3000959 ;PMID: 33798194Full text available |
|
2 |
Material Type: Article
|
Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralizationNature (London), 2021-08, Vol.596 (7871), p.276-280 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Copyright Nature Publishing Group Aug 12, 2021 ;Distributed under a Creative Commons Attribution 4.0 International License ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03777-9 ;PMID: 34237773Full text available |
|
3 |
Material Type: Article
|
Heavily mutated Omicron variant puts scientists on alertNature (London), 2021-12, Vol.600 (7887), p.21-21 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 2, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03552-wFull text available |
|
4 |
Material Type: Article
|
Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.1.351 VariantNew England Journal of Medicine, 2021-05, Vol.384 (20), p.1899-1909 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2103055 ;PMID: 33951374Digital Resources/Online E-Resources |
|
5 |
Material Type: Article
|
Initial report of decreased SARS-CoV-2 viral load after inoculation with the BNT162b2 vaccineNature medicine, 2021-05, Vol.27 (5), p.790-792 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;The Author(s), under exclusive licence to Springer Nature America, Inc. 2021. ;ISSN: 1078-8956 ;EISSN: 1546-170X ;DOI: 10.1038/s41591-021-01316-7 ;PMID: 33782619Full text available |
|
6 |
Material Type: Article
|
WHAT THE DATA SAY ABOUT WEARING FACE MASKSNature (London), 2020-10, Vol.586 (7828), p.186-189 [Peer Reviewed Journal]Copyright Nature Publishing Group Oct 8, 2020 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-020-02801-8Full text available |
|
7 |
Material Type: Article
|
BEYOND OMICRON: WHAT'S NEXT FOR SARS-COV-2 EVOLUTIONNature (London), 2021-12, Vol.600 (7888), p.204-207 [Peer Reviewed Journal]Copyright Nature Publishing Group Dec 9, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/d41586-021-03619-8Full text available |
|
8 |
Material Type: Article
|
Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escapeNature reviews. Immunology, 2021-10, Vol.21 (10), p.626-636 [Peer Reviewed Journal]2021. Springer Nature Limited. ;COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2021. ;Springer Nature Limited 2021 ;ISSN: 1474-1733 ;EISSN: 1474-1741 ;DOI: 10.1038/s41577-021-00592-1 ;PMID: 34373623Full text available |
|
9 |
Material Type: Article
|
Ten scientific reasons in support of airborne transmission of SARS-CoV-2The Lancet (British edition), 2021-05, Vol.397 (10285), p.1603-1605 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)00869-2 ;PMID: 33865497Full text available |
|
10 |
Material Type: Article
|
Genomic evidence for reinfection with SARS-CoV-2: a case studyThe Lancet Infectious Diseases, 2021-01, Vol.21 (1), p.52-58 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(20)30764-7 ;PMID: 33058797Digital Resources/Online E-Resources |
|
11 |
Material Type: Article
|
Characteristics of SARS-CoV-2 and COVID-19Nature reviews. Microbiology, 2021-03, Vol.19 (3), p.141-154 [Peer Reviewed Journal]COPYRIGHT 2021 Nature Publishing Group ;Springer Nature Limited 2020. corrected publication 2022. ;Springer Nature Limited 2020, corrected publication 2022 ;ISSN: 1740-1526 ;EISSN: 1740-1534 ;DOI: 10.1038/s41579-020-00459-7 ;PMID: 33024307Full text available |
|
12 |
Material Type: Article
|
Purnell ChoppinThe Lancet infectious diseases, 2021-09, Vol.21 (9), p.1223-1223 [Peer Reviewed Journal]2021 Elsevier Ltd ;2021. Elsevier Ltd ;ISSN: 1473-3099 ;EISSN: 1474-4457 ;DOI: 10.1016/S1473-3099(21)00495-3Full text available |
|
13 |
Material Type: Article
|
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling studyThe Lancet, 2020-02, Vol.395 (10225), p.689-697 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Elsevier Ltd ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)30260-9 ;PMID: 32014114Digital Resources/Online E-Resources |
|
14 |
Material Type: Article
|
Efficacy of the ChAdOx1 nCoV-19 Covid-19 Vaccine against the B.1.351 VariantNew England Journal of Medicine, 2021-05, Vol.384 (20), p.1885-1898 [Peer Reviewed Journal]Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;Copyright © 2021 Massachusetts Medical Society. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa2102214 ;PMID: 33725432Digital Resources/Online E-Resources |
|
15 |
Material Type: Article
|
An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort studyThe Lancet, 2020-06, Vol.395 (10239), p.1771-1778 [Peer Reviewed Journal]2020 Elsevier Ltd ;Copyright © 2020 Elsevier Ltd. All rights reserved. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020. Elsevier Ltd ;2020 Elsevier Ltd. All rights reserved. 2020 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(20)31103-X ;PMID: 32410760Digital Resources/Online E-Resources |
|
16 |
Material Type: Article
|
Efficacy and safety of an inactivated whole-virion SARS-CoV-2 vaccine (CoronaVac): interim results of a double-blind, randomised, placebo-controlled, phase 3 trial in TurkeyThe Lancet (British edition), 2021-07, Vol.398 (10296), p.213-222 [Peer Reviewed Journal]2021 Elsevier Ltd ;Copyright © 2021 Elsevier Ltd. All rights reserved. ;2021. Elsevier Ltd ;2021 Elsevier Ltd. All rights reserved. 2021 Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(21)01429-X ;PMID: 34246358Full text available |
|
17 |
Material Type: Article
|
Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibody Responses in Coronavirus Disease PatientsEmerging infectious diseases, 2020-07, Vol.26 (7), p.1478-1488 [Peer Reviewed Journal]COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;Published 2020. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2607.200841 ;PMID: 32267220Full text available |
|
18 |
Material Type: Article
|
High Contagiousness and Rapid Spread of Severe Acute Respiratory Syndrome Coronavirus 2Emerging infectious diseases, 2020-07, Vol.26 (7), p.1470-1477 [Peer Reviewed Journal]COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;Published 2020. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2607.200282 ;PMID: 32255761Full text available |
|
19 |
Material Type: Article
|
Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020Emerging infectious diseases, 2020-07, Vol.26 (7), p.1583-1591 [Peer Reviewed Journal]COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;COPYRIGHT 2020 U.S. National Center for Infectious Diseases ;Published 2020. This article is a U.S. Government work and is in the public domain in the USA. ;ISSN: 1080-6040 ;EISSN: 1080-6059 ;DOI: 10.3201/eid2607.200885 ;PMID: 32275497Full text available |
|
20 |
Material Type: Article
|
Virology, transmission, and pathogenesis of SARS-CoV-2BMJ (Online), 2020-10, Vol.371, p.m3862-m3862 [Peer Reviewed Journal]Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to ;This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. https://bmj.com/coronavirus/usage? ;ISSN: 1756-1833 ;EISSN: 1756-1833 ;DOI: 10.1136/bmj.m3862 ;PMID: 33097561Full text available |